ANI PHARMACEUTICALS INC (ANIP) Form 8-K Material Events
ANI PHARMACEUTICALS INC (ANIP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ANIP
CIK: 1023024
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EisnerAmper LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerMichele Epstein
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-16 | 2026-10-15 | FORM 4 | 0001822629-26-000018 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001950047-26-010256 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-13 | FORM 4 | 0001938861-26-000028 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-29 | FORM 4 | 0001674236-26-000024 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-15 | FORM 4 | 0001822629-26-000016 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009487 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-11 | FORM 4 | 0001819879-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-14 | FORM 4 | 0001938861-26-000026 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001950047-26-009361 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-31 | FORM 4 | 0001674236-26-000022 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-19 | FORM 4 | 0001659625-26-000011 | View SEC Doc Filr Page |
| 3 | 2026-08-27 | 2026-08-19 | FORM 3 | 0001659625-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-25 | FORM 4 | 0001822629-26-000014 | View SEC Doc Filr Page |
| 144 | 2026-08-25 | — | 144 Filing | 0001950047-26-008689 | View SEC Doc Filr Page |
| 8-K | 2026-08-24 | 2026-08-19 | 8-K | 0001023024-26-000071 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-13 | FORM 4 | 0001938861-26-000023 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | FORM 4 | 0001846478-26-000015 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001023024-26-000069 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-07 | 8-K | 0001023024-26-000068 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-29 | FORM 4 | 0001674236-26-000019 | View SEC Doc Filr Page |
| 144 | 2026-07-29 | — | 144 Filing | 0001950047-26-007411 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-002156 | View SEC Doc Filr Page |
| 4 | 2026-07-21 | 2026-07-18 | FORM 4 | 0001938861-26-000021 | View SEC Doc Filr Page |
| S-8 | 2026-07-17 | — | S-8 | 0001023024-26-000059 | View SEC Doc Filr Page |
| 4 | 2026-07-14 | 2026-07-13 | FORM 4 | 0001938861-26-000019 | View SEC Doc Filr Page |